or
Bookmark and Share
Purification of ribotoxins and their conjugates
   
Document Number
US Patent 4946943
Issued Date
August 7, 1990
Link
Inventors
Bloch; Will (El Cerrito, CA)
Map
Abstract
The invention herein is directed to methods using Procion dyes to perform separations of interest in manipulating the NAD.sup.+ -independent ribotoxins. The methods are useful for preparing therapeutic agents contaning these ribotoxins of their A polypeptide components. This separation method has been applied in particular to preparing hybrid toxins containing ricin toxins, both of purifying the resulting products and also for separating the components intended to be used in the preparation of these end products. In addition, a novel ricin isotoxin prepared using the method of the invention is disclosed.
Drawing
Purification of ribotoxins and their conjugates - US Patent 4946943 Drawing
Drawing from US Patent 4946943
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
20
Comments:
no comments yet
Owner
Published
August 7, 1990
Application Number
07/158,092
Filed
February 16, 1988
US Classification
530/377   424/183.1 530/350 530/370 530/391.7 530/415 530/417
Int'l Classification
C07K   19/00   (20060101)   C07K   14/415   (20060101)   A61K   38/00   (20060101)  
Parent Case
This application is a continuation of application Ser. No. 747,114 filed June 20, 1985, now abandoned.
USPTO Field of Search
530/350   530/370   530/377  
Related Patents
5840522 - Recombinant lectins - Owned by Chiron Corporation (Emeryville, CA)

DNA sequences encoding full length precursor proteins, which proteins contain both A and B portions of two ricin isotoxins and ricin agglutinin, as well as the linker regions have been determined. These DNAs or portions or modifications thereof are expressed in recombinant hosts to obtain the desired proteins or proteins which can readily converted thereto. One of the ricin isotoxins may be related to ricin E.

5679653 - Diagnosis and treatment of bacterial dystentery - Owned by Synsorb Biotech Inc. (Calgary,CA)

Diagnostic and therapeutic compositions which comprise the .alpha.Gal(1-4).beta.Gal subunit are described. These compositions permit the rapid diagnosis and treatment of enteric infections caused by E. coli that produce shiga-like toxins (SLT).

5955449 - Diagnosis and treatment of bacterial dysentery - Owned by SYNSORB Biotech Inc. (Calgary,CA)

Diagnostic and therapeutic compositions which comprise the .alpha.Gal(1-4).beta.Gal subunit are described. These compositions permit the rapid diagnosis and treatment of enteric infections caused by E. coli that produce shiga-like toxins (SLT).

5620858 - Method of removing shiga-like toxins from biological samples - Owned by Synsorb Biotech Inc. (Calgary,CA)

Diagnostic and therapeutic compositions which comprise the .alpha.Gal(1-4).beta.Gal subunit are described. These compositions permit the rapid diagnosis and treatment of enteric infections caused by E. coli that produce shiga-like toxins (SLT).

6084073 - Recombinant ricin toxin - Owned by Chiron Corporation (Emeryville, CA)

DNA sequences encoding full length precursor proteins, which proteins contain both A and B portions of two ricin isotoxins and ricin agglutinin, as well as the linker regions have been determined. These DNAs or portions or modifications thereof are expressed in recombinant hosts to obtain the desired proteins or proteins which can readily converted thereto. One of the ricin isotoxins may be related to ricin E.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us